Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation - Liberty - Outstanding Awards (Details)

v3.22.2
Stock-Based Compensation - Liberty - Outstanding Awards (Details)
$ / shares in Units, $ in Millions
 6 Months Ended
Jun. 30, 2022
USD ($)
$ / shares
shares
Additional disclosures  
Total unrecognized compensation cost related to unvested equity awards | $ $ 44
Weighted average period of recognition related to unvested equity awards (in years) 1 year 8 months 12 days
Liberty SiriusXM Group  
Additional disclosures  
Common stock reserved for issuance 7,100,000
Liberty SiriusXM Group | Common Class A  
Number of options  
Granted 0
Outstanding at end of period 0
Liberty SiriusXM Group | Common Class B  
Number of options  
Granted 0
Outstanding at end of period 0
Liberty SiriusXM Group | Series C  
Number of options  
Outstanding at beginning of period 7,369,000
Granted 212,000
Exercised (441,000)
Outstanding at end of period 7,140,000
Exercisable at end of period 4,774,000
WAEP  
Outstanding at beginning of period | $ / shares $ 38.79
Granted | $ / shares 44.80
Exercised | $ / shares 31.25
Outstanding at end of period | $ / shares 39.43
Exercisable at end of period | $ / shares $ 36.87
Additional disclosures  
Weighted average remaining life, outstanding 3 years 2 months 12 days
Weighted average remaining life, exercisable 2 years 3 months 18 days
Aggregate intrinsic value, outstanding | $ $ 9
Aggregate intrinsic value, exercisable | $ $ 9
Formula One Group  
Additional disclosures  
Common stock reserved for issuance 8,200,000
Formula One Group | Common Class A  
Number of options  
Granted 0
Formula One Group | Common Class B  
Number of options  
Granted 0
Outstanding at end of period 0
Formula One Group | Series C  
Number of options  
Outstanding at beginning of period 9,114,000
Granted 267,000
Exercised (1,184,000)
Outstanding at end of period 8,197,000
Exercisable at end of period 6,367,000
WAEP  
Outstanding at beginning of period | $ / shares $ 34.38
Granted | $ / shares 57.67
Exercised | $ / shares 31.63
Outstanding at end of period | $ / shares 35.54
Exercisable at end of period | $ / shares $ 32.75
Additional disclosures  
Weighted average remaining life, outstanding 4 years 1 month 6 days
Weighted average remaining life, exercisable 3 years 9 months 18 days
Aggregate intrinsic value, outstanding | $ $ 229
Aggregate intrinsic value, exercisable | $ $ 196
Braves Group  
Additional disclosures  
Common stock reserved for issuance 3,200,000
Braves Group | Common Class A  
Number of options  
Granted 0
Outstanding at end of period 1,000
Exercisable at end of period 1,000
WAEP  
Outstanding at end of period | $ / shares $ 12.35
Exercisable at end of period | $ / shares $ 12.35
Additional disclosures  
Weighted average period of recognition related to unvested equity awards (in years) 6 months
Braves Group | Common Class B  
Number of options  
Granted 0
Outstanding at end of period 0
Braves Group | Series C  
Number of options  
Outstanding at beginning of period 3,125,000
Granted 95,000
Exercised (63,000)
Outstanding at end of period 3,157,000
Exercisable at end of period 586,000
WAEP  
Outstanding at beginning of period | $ / shares $ 25.86
Granted | $ / shares 25.49
Exercised | $ / shares 18.14
Outstanding at end of period | $ / shares 26.00
Exercisable at end of period | $ / shares $ 20.85
Additional disclosures  
Weighted average remaining life, outstanding 4 years 9 months 18 days
Weighted average remaining life, exercisable 2 years 3 months 18 days
Aggregate intrinsic value, outstanding | $ $ 2
Aggregate intrinsic value, exercisable | $ $ 2